CA1059128A - Piperazinyl pyrazines - Google Patents

Piperazinyl pyrazines

Info

Publication number
CA1059128A
CA1059128A CA250,732A CA250732A CA1059128A CA 1059128 A CA1059128 A CA 1059128A CA 250732 A CA250732 A CA 250732A CA 1059128 A CA1059128 A CA 1059128A
Authority
CA
Canada
Prior art keywords
pyrazine
piperazinyl
chloro
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA250,732A
Other languages
English (en)
French (fr)
Inventor
Walfred S. Saari
William C. Lumma (Jr.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA1059128A publication Critical patent/CA1059128A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA250,732A 1975-04-21 1976-04-14 Piperazinyl pyrazines Expired CA1059128A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57005275A 1975-04-21 1975-04-21

Publications (1)

Publication Number Publication Date
CA1059128A true CA1059128A (en) 1979-07-24

Family

ID=24277994

Family Applications (1)

Application Number Title Priority Date Filing Date
CA250,732A Expired CA1059128A (en) 1975-04-21 1976-04-14 Piperazinyl pyrazines

Country Status (36)

Country Link
JP (1) JPS51136688A (xx)
AR (1) AR210349A1 (xx)
AT (1) AT353795B (xx)
AU (1) AU496854B2 (xx)
BE (1) BE840904A (xx)
BG (1) BG34185A3 (xx)
CA (1) CA1059128A (xx)
CH (1) CH619462A5 (xx)
CS (1) CS195726B2 (xx)
CY (1) CY1090A (xx)
DD (1) DD124599A5 (xx)
DE (1) DE2617205C3 (xx)
DK (1) DK143899C (xx)
EG (1) EG12387A (xx)
ES (4) ES447150A1 (xx)
FI (1) FI62666C (xx)
FR (1) FR2308367A1 (xx)
GB (1) GB1492528A (xx)
GR (1) GR59900B (xx)
HK (1) HK60380A (xx)
HU (1) HU172684B (xx)
IE (1) IE42979B1 (xx)
IL (1) IL49391A (xx)
KE (1) KE3088A (xx)
LU (1) LU74795A1 (xx)
MY (1) MY8100225A (xx)
NL (1) NL167692C (xx)
NO (1) NO146599C (xx)
PH (1) PH12274A (xx)
PL (1) PL99664B1 (xx)
PT (1) PT65027B (xx)
RO (1) RO73278A (xx)
SE (1) SE421695B (xx)
SU (1) SU638260A3 (xx)
YU (1) YU100676A (xx)
ZA (1) ZA762320B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091098A (en) * 1977-04-25 1978-05-23 Merck & Co., Inc. 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides
US4163849A (en) 1978-03-17 1979-08-07 Merck & Co., Inc. Piperazinylpyrazines
US4252816A (en) * 1979-12-03 1981-02-24 Merck & Co., Inc. Tetrahydro-1H-1,4-diazepino(1,7-a)benzimidazoles useful as analgesic agents
US4339579A (en) 1980-12-29 1982-07-13 American Home Products Corporation 2,6-Bis-(pyrrolopyrazinyl)pyrazines
EP0094498A3 (en) * 1982-05-06 1985-04-03 American Cyanamid Company Antiatherosclerotic 1-piperazine derivatives
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
EP0580465A1 (fr) * 1992-06-25 1994-01-26 Sanofi Nouvelle utilisation thérapeutique d'hétérocyclyl-pipérazines comme 5-HT3 agonistes et nouveaux dérivés
DK1027336T3 (da) * 1997-10-27 2005-01-24 Neurosearch As Heteroaryldiazacycloalkaner, deres fremstilling og anvendelse
NZ514021A (en) 1999-04-26 2001-09-28 Neurosearch As Heteroaryl diazacycloalkanes, their preparation and use
BR0108363A (pt) * 2000-02-16 2004-02-10 Neurogen Corp Composto, métodos para modular função de receptor de crf e acoplado a proteìna g, para tratar um distúrbio ou doença do snc, para localizar receptores de crf em amostras de seção de tecidos, para inibir a ligação de crf a um receptor de crf¹ e para alterar a atividade de transdução de sinal de um receptor de crf¹ e composição farmacêutica
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
SE0202287D0 (sv) * 2002-07-19 2002-07-19 Biovitrum Ab New compounds
DE60311822T2 (de) * 2002-07-19 2007-12-06 Biovitrum Ab Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606906A (en) * 1948-10-14 1952-08-12 American Cyanamid Co 1-(2-pyridyl) piperazine and process of preparing same

Also Published As

Publication number Publication date
HK60380A (en) 1980-11-07
DE2617205A1 (de) 1976-10-28
NL167692C (nl) 1982-01-18
EG12387A (en) 1978-12-31
ATA288376A (de) 1979-05-15
KE3088A (en) 1980-11-07
ES459407A1 (es) 1978-08-16
NO146599B (no) 1982-07-26
IL49391A (en) 1979-09-30
NO761207L (xx) 1976-10-22
BG34185A3 (en) 1983-07-15
AU1296676A (en) 1977-10-20
JPS51136688A (en) 1976-11-26
DE2617205B2 (de) 1980-05-08
FI62666C (fi) 1983-02-10
NL167692B (nl) 1981-08-17
SE421695B (sv) 1982-01-25
PT65027B (en) 1978-04-03
AT353795B (de) 1979-12-10
LU74795A1 (xx) 1977-02-07
ES459406A1 (es) 1978-08-16
DK143899C (da) 1982-04-13
AU496854B2 (en) 1978-11-02
ZA762320B (en) 1977-11-30
GR59900B (en) 1978-03-16
DK143899B (da) 1981-10-26
BE840904A (fr) 1976-08-16
IE42979L (en) 1976-10-21
CY1090A (en) 1980-12-27
FI760978A (xx) 1976-10-22
MY8100225A (en) 1981-12-31
DK164476A (da) 1976-10-22
JPS5522475B2 (xx) 1980-06-17
ES447150A1 (es) 1977-09-16
DD124599A5 (xx) 1977-03-02
GB1492528A (en) 1977-11-23
PT65027A (en) 1976-05-01
RO73278A (ro) 1982-09-09
AR210349A1 (es) 1977-07-29
YU100676A (en) 1982-08-31
SU638260A3 (ru) 1978-12-15
PH12274A (en) 1978-12-12
PL99664B1 (pl) 1978-07-31
NO146599C (no) 1982-11-03
CS195726B2 (en) 1980-02-29
FR2308367A1 (fr) 1976-11-19
FR2308367B1 (xx) 1979-09-21
IE42979B1 (en) 1980-11-19
NL7603800A (nl) 1976-10-25
HU172684B (hu) 1978-11-28
IL49391A0 (en) 1976-06-30
DE2617205C3 (de) 1981-01-29
CH619462A5 (en) 1980-09-30
FI62666B (fi) 1982-10-29
SE7604093L (sv) 1976-10-22
ES459405A1 (es) 1978-08-16

Similar Documents

Publication Publication Date Title
CA1059128A (en) Piperazinyl pyrazines
US6599905B2 (en) Pyrazine compounds
SU1340589A3 (ru) Способ получени 2-(4-замещенных пиперазино-4-амино-6,7-диметокси)хинолинов или их гидрохлоридов
US4081542A (en) Piperazinylpyrazines
US3300494A (en) Pyrazinamidoguanidine products
JPH0224821B2 (xx)
US4082844A (en) 6-chloro-2-(1-piperazinyl)pyrazine
US4118561A (en) 7-(Substituted)-7H-pyrrolo[3,2-f]quinazoline-1,3-diamines
US6503909B1 (en) Pyrazine compounds
US4379160A (en) Carbazole compounds and medicinal use thereof
US4242344A (en) Piperazinyl-imidazo[1,2-a]pyrazines
JP2002505999A (ja) 新規な四環化合物、その製造方法およびこれらの化合物を含有する医薬製剤
JP3038064B2 (ja) インドール誘導体およびこれを有効成分とする抗潰瘍薬
JPS59216877A (ja) 置換フエニル−2−(1h)−ピリミジノン
US4144338A (en) N-pyrimidinyl-N-dialkylaminoalkyl ureas
US5290933A (en) Phenylpyrimidone derivatives
US4011323A (en) Bi-4-[1-(quinazolinyl-4)piperidyls] and bis{4-[1-(quinazolinyl-4)piperidyl]alkanes}
CA1293251C (en) Pyrazine derivative, a process for preparation thereof and pharmaceutical composition therefrom
US3708484A (en) Amino and substituted amino-s-triazolo-(4,3-b)-pyridazines
CA1093555A (en) 7-(substituted)-7h-pyrrolo¬3,2-f| quinazoline-1,3- diamines
KR790001500B1 (ko) 피페라지닐 피라진 화합물의 제법
US4874763A (en) Pharmaceutically efficacious pteridine derivatives
US4029788A (en) 2,3-Bis(4-alkyl-1-piperazinyl)quinoxalines
US4154947A (en) Heterocyclic substituted benzylideneaminoguanidines
US4066643A (en) Pyrazolo[1,5-a]pyrido[3,2-e]pyrimidine-7-carboxylic acid derivatives